kenvue stock tylenol - Search News

Kimberly-Clark to buy maker of Tylenol

· 2d · on MSN

Kimberly-Clark to Buy Tylenol Maker Kenvue. Why the Stock Market Hates the Deal.

The firm noted that Kimberly-Clark is paying a “significant equity premium” to acquire Kenvue. The deal values Kenvue at $19.25 a share. Even with Monday’s gains, the stock was trading at under $17.

Continue reading

· 2d · on MSN

Kimberly-Clark to acquire Tylenol maker Kenvue in $48.7 billion deal

Kimberly-Clark to buy maker of Tylenol in $48.7 billion cash-and-stock deal

Tylenol, Kleenex, Band-Aid and more put under one roof in $48.7 billion consumer brands deal

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.

Continue reading

Kimberly-Clark to buy Tylenol maker Kenvue in massive consumer merger

Kimberly-Clark to buy Tylenol maker Kenvue for $48.7-billion

2d

Kenvue stock share price today: Kimberly-Clark to acquire Tylenol maker Kenvue for $40 billion in cash and stock deal. Here's background, current challenges, future outlook ...

Kenvue stock share price today shows a major surge after Kimberly-Clark announced plans to buy Kenvue for over $40 billion. The cash-and-stock deal will merge brands like Huggies, Kleenex, Tylenol, and Band-Aid under one company,